• Estado: Abierto
  • Ámbito: UE
  • Tipo: Proyecto de Investigación
  • Organismo: Comisión Europea
  • Referencia: 768641
  • Acrónimo: AllerScreening
  • Título: Point-of-care device base on KETs for diagnosis of food allergies
  • IP: Torres Jaén, María José
  • Grupo IBIMA: D-04
  • Centro de vinculación: HRUM
  • Sitio web proyecto:
  • Fecha inicio: 01/10/2021
  • Fecha fin: 01/10/2021
  • Rol en el proyecto
  • Abstract: Food allergy is an immune-based disease that has become an important public health problem that affects children and adults and may be increasing in prevalence.In the US, food allergy affects 5% of children under the age of 5 years and 4% of teens and adults, and its prevalence appears to be on the increase. Globally, it is estimated that over 6% of the population, around 200 to 250 million people, suffer from some food allergies, affecting more than 17 million people only in Europe.The main objective of this proposal is translating an optical diagnostic technology already proven in which the novel AllerScreening platform is based on, to the clinical routine, addressing a priority healthcare unmet need from the laboratory to the clinic. The unique features of AllerScreening will allow clinicians to early detect main food allergies (at least the 90% of European food allergies) through a simple test using a drop of sera, reducing the cost and technical requirements of the current clinical practice. This new and innovative cost-effective sensing system for the in vitro component diagnosis of food allergies will be feasible thanks to the multiplexed disposable BioKits and the optical Pont-of-Care (PoC) reader in which the novel AllerScreening platform is based on, allowing the adoption of a novel PoC diagnostic device specific for food allergies.


Suscríbete a nuestro Newsletter y recibe en tu correo todas las últimas novedades del Instituto.
Consulta el histórico de Newsletter:

Calle Doctor Miguel Díaz Recio , 28 Málaga 29010

(+34) 951 440 260
Fax: (+34) 951 440 263